Mason Street Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mason Street Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-30,925	Closed	-$397K	–	1627
2014 Q4	$397K	Hold	30,925	–	–	﹤0.01%	1352
2014 Q3	$336K	Hold	30,925	–	–	﹤0.01%	1379
2014 Q2	$397K	Hold	30,925	–	–	﹤0.01%	1346
2014 Q1	$319K	Buy	+30,925	New	+$348K	﹤0.01%	1360

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mason Street Advisors's IRWD Position: Q1 2015 in Review

Mason Street Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2015, closing a stake of 30,925 shares — an estimated $397K sold.

Mason Street Advisors first reported a position in IRWD in Q1 2014 and held it in 4 quarters. The position peaked at $397K in Q4 2014. 142 funds tracked by Wall St. Rank hold IRWD as of Q1 2015.

Mason Street Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 30,925 Ironwood Pharmaceuticals shares in Q1 2015, an estimated $397K.
Mason Street Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 4 quarters.
Mason Street Advisors's Ironwood Pharmaceuticals position peaked at $397K in Q4 2014.
142 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.